Indo Count Industries Ltd

- As per the discussion on Page 17, there are no major investments or new fundraising plans currently lined up for the next 18 to 24 months related to the aspiration of doubling revenues. - The company has a strong balance sheet and is always evaluating opportunities, but as of now, no new debt or equity raising is planned beyond what has already been invested. - Incremental investments for growth beyond the current guidance would only be considered if new opportunities arise. - Debt levels are expected to remain stable or reduce, with no major fluctuations anticipated in the upcoming years (Page 16). - Debt is primarily needed to support working capital as revenue grows, not for major capex. - Capex for FY '27 is projected around INR 125-150 crores, mainly for balancing and maintenance, with no major capex spikes expected. In summary, no immediate or planned fundraising through debt or equity is indicated.

- For FY '26, planned capex was around INR 214 crores; actual investment till 9 months was INR 131 crores, expected to reach about INR 150 crores by year-end. - Some capex related to Zero Liquid Discharge (ZLD) technology is in the final stages and will spill over into FY '27. - Normal balancing and maintenance capex will continue into FY '27. - No major new investments are currently lined up beyond those required to support the aspiration to double revenues, with large investments for that already in place. - The company continuously evaluates opportunities for further growth and is financially strong to invest when opportunities arise. - Post peak investment cycle, debt levels are expected to reduce as revenue and margins improve. - Capex focus includes ramping existing facilities, with attention to U.S. greenfield projects and utility bedding businesses.

- Indo Count aims to double revenues by FY 2028, supported by a balanced mix of business segments, geographies, strong brands, and expanded global manufacturing. - New businesses (utility bedding and U.S. brand portfolio) are on a growth trajectory, currently at nearly USD 100 million run rate, targeting USD 275 million in 3 years. - Core business growth expected with improved operating environment and enhanced competitive positioning, including benefits from trade agreements (FTA with U.S. and Europe). - Capacity utilization expected to ramp up in FY 27, including U.S. greenfield facilities targeting 50% utilization next year. - Sales volumes are anticipated to exceed current levels, with a question raised about exceeding 100 million meters in FY 27—management indicates it's too early to confirm specific volume guidance but aims for better performance. - The company remains agile to capitalize on new opportunities with a strong balance sheet and focus on sustaining high growth momentum.

- The company targets doubling revenues by FY '28, supported by core and new businesses (utility bedding and U.S. brands) scaling up to around USD 275 million. - Margins are expected to recover from current tariff-related pressures, aiming to return to historic 15-16% EBITDA levels over 6-8 quarters as tariffs normalize and capacity utilization improves. - The incubation costs impacting margins (~150-200 bps) are expected to end by Q4 FY '26, leading to margin improvement. - EPS stood at INR 1.23 per share in Q3 FY '26, with expectations of stronger EBITDA to PAT conversion over the next 2 years as volumes and new businesses grow. - Debt levels should stabilize or reduce due to no major capex planned, supporting healthier financials. - Overall, earnings growth is linked to ramp-up of U.S. onshore activities, expanding geographic diversification, and improving consumer demand conditions.

The transcript from the Indo Count Industries Limited Q3 & 9M FY26 investor call on February 16, 2026, does not explicitly provide specific details about the current or expected order book or pending orders in quantifiable terms. However, relevant insights include: - The company is experiencing strong demand visibility, particularly with expectations of improved utilization levels as FTAs with the U.K. and EU get ratified in the next two quarters. - The U.S. business is at a USD100 million run rate with positive outlook and capacity expansion. - Discussions with customers indicate growing engagement and order flow once tariff and trade uncertainties resolve. - The company is optimistic about scaling revenues, including new businesses and branded products contributing to growth. - While exact order book numbers are not disclosed, management remains cautiously optimistic, emphasizing improved scale, capacity utilization, and expanding customer engagement as orders pick up. No direct numerical order backlog or pending order values were shared in the transcript.